Success Metrics

Clinical Success Rate
89.3%

Based on 100 completed trials

Completion Rate
89%(100/112)
Active Trials
2(2%)
Results Posted
51%(51 trials)
Terminated
12(9%)

Phase Distribution

Ph not_applicable
12
9%
Ph phase_1
29
22%
Ph phase_3
22
17%
Ph phase_4
30
23%
Ph phase_2
32
25%
Ph early_phase_1
4
3%

Phase Distribution

33

Early Stage

32

Mid Stage

52

Late Stage

Phase Distribution129 total trials
Early Phase 1First-in-human
4(3.1%)
Phase 1Safety & dosage
29(22.5%)
Phase 2Efficacy & side effects
32(24.8%)
Phase 3Large-scale testing
22(17.1%)
Phase 4Post-market surveillance
30(23.3%)
N/ANon-phased studies
12(9.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.0%

100 of 119 finished

Non-Completion Rate

16.0%

19 ended early

Currently Active

2

trials recruiting

Total Trials

129

all time

Status Distribution
Active(4)
Completed(100)
Terminated(19)
Other(6)

Detailed Status

Completed100
Terminated12
Withdrawn7
unknown6
Not yet recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
129
Active
2
Success Rate
89.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.1%)
Phase 129 (22.5%)
Phase 232 (24.8%)
Phase 322 (17.1%)
Phase 430 (23.3%)
N/A12 (9.3%)

Trials by Status

terminated129%
completed10078%
not_yet_recruiting22%
unknown65%
recruiting22%
withdrawn75%

Recent Activity

Clinical Trials (129)

Showing 20 of 129 trialsScroll for more
NCT07549490Not Applicable

Human Experimental Models of Pain (HEMP)

Not Yet Recruiting
NCT07277712Phase 1

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

Not Yet Recruiting
NCT05851976Phase 4

Duloxetine for LBP

Recruiting
NCT04038346Phase 3

Symptomatic Management of Lyme Arthritis

Terminated
NCT05411718Phase 2

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Recruiting
NCT07204379Early Phase 1

Effect of Oral Analgesics on Post-op Pain

Completed
NCT03493945Phase 1

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

Completed
NCT04115098Phase 2

Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials

Terminated
NCT06948513Phase 3

Effect of Over-the-counter Analgesics on Postoperative Pain

Completed
NCT03771612Early Phase 1

Inflammation and Daily Life Study

Completed
NCT03654326Phase 2

A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)

Completed
NCT02611466Phase 2

A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

Completed
NCT05995912Phase 2

Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain

Completed
NCT02451748Phase 4

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Completed
NCT04694300Phase 4

OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

Completed
NCT05087914Phase 2

Novel Non-opioid Post-surgical Pain Treatment in Females

Withdrawn
NCT02667730Phase 4

Correlation Between Acute Analgesia and Long-Term Function Following Ankle Injuries

Completed
NCT02502006Phase 1

Variability in Response to Non-steroidal Anti-inflammatory Drugs

Terminated
NCT03697720Phase 4

Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

Completed
NCT03949673Phase 2

Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
129